Assessment of left ventricular function with magnetic resonance imaging vs. echocardiography, contrast echocardiography, and single-photon emission computed tomography in patients with recent ST-elevation myocardial infarction.

AIMS Magnetic resonance imaging (MRI) is often considered to be the gold standard in measuring left ventricular function and volumes. The aim of this study was to assess the agreements between standard echocardiography (standard echo), contrast echocardiography (contrast echo), single-photon emission computed tomography (SPECT), and MRI in the determination of left ventricular ejection fraction (EF) and end-diastolic volumes (EDV) in patients treated for acute ST-elevation myocardial infarction (STEMI). METHODS AND RESULTS Standard echo, contrast echo, SPECT and MRI were performed on the same day, 3 months after STEMI in 150 patients participating in the NORwegian Study on District Treatment of ST-Elevation Myocardial Infarction (NORDISTEMI). Bland-Altman analysis of EF measured by all four imaging modalities showed generally low mean differences but wide limits of agreement. The mean EDV difference, however, was consistently higher when MRI was compared with standard echo (54.9 mL), contrast echo (41.7 mL) and SPECT (54.6 mL), and the limits of agreement were wider. The mean EDV differences between contrast echo vs. standard echo, SPECT vs. standard echo and contrast echo vs. SPECT were small. CONCLUSION Our data suggest that all four imaging modalities measured EF closely similar after STEMI as demonstrated by a very small bias. The limits of agreement were however wide. EDV measured by MRI was consistently higher when compared with the other methods which may be caused by different tracing-methods and imaging principles. As echocardiography is preferable from a cost-benefit point of view, further analysis would be needed to clarify the nature of such differences.

[1]  S. Kjeldsen,et al.  Left ventricular function in acute myocardial infarction treated with thrombolysis followed by early versus late invasive strategy. , 2010, American heart journal.

[2]  S. Halvorsen,et al.  Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). , 2010, Journal of the American College of Cardiology.

[3]  N. Chiu,et al.  Diagnostic efficacy of a low-dose 32-projection SPECT 99mTc-sestamibi myocardial perfusion imaging protocol in routine practice , 2009, Nuclear medicine communications.

[4]  Scott H. Settlemier,et al.  Quantitative assessment of left ventricular volume and ejection fraction using two-dimensional speckle tracking echocardiography. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[5]  N. Hagiwara,et al.  Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry , 2008, Heart.

[6]  H. Demir,et al.  Comparison of gated SPECT, echocardiography and cardiac magnetic resonance imaging for the assessment of left ventricular ejection fraction and volumes , 2007, Annals of Saudi medicine.

[7]  S. Halvorsen,et al.  The NORwegian study on DIstrict treatment of ST-Elevation Myocardial Infarction (NORDISTEMI) , 2007, Scandinavian cardiovascular journal : SCJ.

[8]  T. Naqvi,et al.  A new window of opportunity in echocardiography. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[9]  S. Halvorsen,et al.  Myocardial perfusion in ST-elevation myocardial infarction treated successfully with primary angioplasty , 2006, Scandinavian cardiovascular journal : SCJ.

[10]  Sigmund Frigstad,et al.  Accurate and reproducible measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. , 2004, Journal of the American College of Cardiology.

[11]  Matthias Günther,et al.  Ultrasound‐guided MRI: Preliminary results using a motion phantom , 2004, Magnetic resonance in medicine.

[12]  D. Pennell,et al.  Cardiovascular magnetic resonance , 2001, Heart.

[13]  R. Kim,et al.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.

[14]  R. Kim,et al.  Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance Imaging , 2002, Circulation.

[15]  M. Enriquez-Sarano,et al.  Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. , 2000, Journal of the American College of Cardiology.

[16]  Jeroen J. Bax,et al.  Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular function in ischemic cardiomyopathy. , 2000, The American journal of cardiology.

[17]  D J Pennell,et al.  Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? , 2000, European heart journal.

[18]  R M Peshock,et al.  Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. , 1998, Journal of the American College of Cardiology.

[19]  J. Cohn,et al.  Prognostic Significance of Serial Changes in Left Ventricular Ejection Fraction in Patients With Congestive Heart Failure , 1993, Circulation.

[20]  S. Yusuf,et al.  Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. , 1992, Circulation.

[21]  S. Yusuf,et al.  Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril on the Long‐term: Progression of Left Ventricular Dysfunction in Patients With Heart Failure , 1992, Circulation.

[22]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[23]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.